Author introduction:
The history of leprosy dates back to the time of human existence and is also mentioned in the Avesta. The Vandidad refers to Thrita as the first Aryan physician who was capable of treating several diseases including leprosy. However, no visual example indicating the effect of leprosy on the Iranian culture and artifacts has been reported while it can be seen in other cultures in forms of paintings, carvings, and even the remaining masks. The author has recently found something in the remains of the Teppe Hasanlu dating back to the 1st millennium BC which can be considered as the first visual instance of the effect of leprosy on the Iranian art.
The Teppe Hasanlu civilization belongs to the northwest of Iran. Through excavations, ten different eras were detected at the hill, the most outstanding of which dates back to the 4th era, i.e. 133–800 BC.
BT - Iranian journal of public health C1 -http://www.ncbi.nlm.nih.gov/pubmed/26587487?dopt=Abstract
IS - 8 J2 - Iran. J. Public Health LA - eng N2 -Author introduction:
The history of leprosy dates back to the time of human existence and is also mentioned in the Avesta. The Vandidad refers to Thrita as the first Aryan physician who was capable of treating several diseases including leprosy. However, no visual example indicating the effect of leprosy on the Iranian culture and artifacts has been reported while it can be seen in other cultures in forms of paintings, carvings, and even the remaining masks. The author has recently found something in the remains of the Teppe Hasanlu dating back to the 1st millennium BC which can be considered as the first visual instance of the effect of leprosy on the Iranian art.
The Teppe Hasanlu civilization belongs to the northwest of Iran. Through excavations, ten different eras were detected at the hill, the most outstanding of which dates back to the 4th era, i.e. 133–800 BC.
PY - 2015 SP - 1162 EP - 1163 T2 - Iranian journal of public health TI - First Visual Evidence of Leprosy in the Continental Shelf of Iran. UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645743/ VL - 44 SN - 2251-6085 ER -